You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PREDNICARBATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prednicarbate patents expire, and what generic alternatives are available?

Prednicarbate is a drug marketed by Fougera Pharms and is included in two NDAs.

The generic ingredient in PREDNICARBATE is prednicarbate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prednicarbate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prednicarbate

A generic version of PREDNICARBATE was approved as prednicarbate by FOUGERA PHARMS on March 9th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PREDNICARBATE?
  • What are the global sales for PREDNICARBATE?
  • What is Average Wholesale Price for PREDNICARBATE?
Summary for PREDNICARBATE
Drug patent expirations by year for PREDNICARBATE
Drug Prices for PREDNICARBATE

See drug prices for PREDNICARBATE

Recent Clinical Trials for PREDNICARBATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Handok Inc.Phase 4
Handok Pharmaceuticals Co., Ltd.Phase 4

See all PREDNICARBATE clinical trials

Pharmacology for PREDNICARBATE

US Patents and Regulatory Information for PREDNICARBATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PREDNICARBATE prednicarbate CREAM;TOPICAL 077287-001 Sep 19, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms PREDNICARBATE prednicarbate OINTMENT;TOPICAL 077236-001 Mar 9, 2007 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.